# FDA recall D-1436-2014

> **Teva Pharmaceuticals USA** · Class III · drug recall initiated 2014-06-17.

## Product

Apri (desogestrel and ethinyl estradiol tablets USP), 0.15 mg/0.03 mg,  6 Cyclic dispensers X 28 tablets, Rx only, Teva Pharmaceuticals, Sellersville, PA. NDC 0555-9043-58

## Reason for recall

Failed Impurities/Degradation Specifications: out of specification impurity test results.

## Distribution

Nationwide

## Key facts

- **Recall number:** D-1436-2014
- **Recalling firm:** Teva Pharmaceuticals USA
- **Classification:** Class III
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2014-06-17
- **Report date:** 2014-07-23
- **Termination date:** 2015-03-09

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** North Wales, PA, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-1436-2014

## Citation

> AI Analytics. FDA recall D-1436-2014. Retrieved 2026-05-29 from https://api.ai-analytics.org/recall/D-1436-2014. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*